AI could predict which heart patients need extra care after stent surgery

NCT ID NCT07312318

Recruiting now Knowledge-focused Sponsor: China-Japan Friendship Hospital Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This large study in China will enroll 12,000 heart disease patients who have had or will have a stent procedure (PCI). Researchers will collect blood samples, imaging, and health data to train an artificial intelligence system. The goal is to predict which patients are likely to experience worsening of other untreated blockages, so doctors can intervene earlier and personalize follow-up care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a new AI tool that helps doctors identify which heart patients are at highest risk of future problems after stent surgery, enabling earlier and more personalized treatment.
What could go wrong: This is an observational study, not a treatment trial, so it won't directly test a new drug or therapy. The AI model may not work as well in other populations or settings, and it will take years to develop and validate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY HEART DISEASE (CHD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder Coronary Disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CORONARY HEART DISEASE (CHD)

Contacts and locations

Locations

China-Japan Friendship Hospital
RECRUITING

Beijing, Beijing Municipality, 100029, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.